Skip to main content
KnowGovUnderstand. Power. Act.
← Data Lab

The Library

New

One story, all the way down.

FDA Panel Endorses First-Of-A-Kind Cancer Blood Test From Grail

WASHINGTON (AP) — Federal health advisers on Wednesday endorsed a blood test designed to spot signs of various cancers in apparently healthy people while warning that it's far from clear how well the technology works.

Coverage (1)+6 copies· Sep 23, 1:22 PM to Sep 24, 10:01 AM

fda cancer test endorsementfda panel voteHealthJustice
Read it

Every telling

their own versions

How it spread

7 articles
  1. firstU.S. News & World Report
  2. firstWDIV ClickOnDetroit
  3. +7hPittsburgh Tribune-Review
  4. +9hThe Atlanta Journal-Constitution
  5. +21hWEAU
  6. +21hWIS10
  7. +21hLive 5 News WCSC

The thread

fda cancer test endorsement →

Since

More like this

similar stories in the archive
Grail's cancer blood test faces high-stakes FDA reviewA blood test to hunt signs of multiple cancers in healthy people is facing its first major U.S. regulatory hurdle. Federal health advisers meet Wednesday to recommend whether Grail Inc.'s test should be cleared for people 50 and older. It's the first time the technology has come before the Food and Drug Administration, which will make the final decision.…
The Atlanta Journal-Constitution13d agoWhole story →
Healthfda review of cancer blood test